Peritoneal Surface Disease (PSD) from Appendiceal Cancer Treated with Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Overview of 481 ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2015-04

AUTHORS

Konstantinos I. Votanopoulos, Greg Russell, Reese W. Randle, Perry Shen, John H. Stewart, Edward A. Levine

ABSTRACT

BACKGROUND: Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) used to treat peritoneal surface disease (PSD) from appendiceal cancer have shown variability in survival outcomes. The primary goal of this study was to determine predictors of surgical morbidity and overall survival. The secondary goal was to describe the impact of nodal status on survival after CRS/HIPEC for PSD from low-grade appendiceal (LGA) and high-grade appendiceal (HGA) primary lesions. METHODS: A retrospective analysis of 1,069 procedures from a prospective database was performed. Patient characteristics, tumor grade, nodal status, performance status, resection status, morbidity, mortality, and survival were reviewed. RESULTS: The study identified 481 CRS/HIPEC procedures: 317 (77.3 %) for LGA and 93 (22.7 %) for HGA lesions. The median follow-up period was 44.4 months, and the 30-day major morbidity and mortality rates were respectively 27.8 and 2.7 %. Major morbidity was jointly predicted by incomplete cytoreduction (p = 0.0037), involved nodes (p < 0.0001), and comorbidities (p = 0.003). Multivariate negative predictors of survival included positive nodal status (p = 0.003), incomplete cytoreduction (p < 0.0001), and preoperative chemotherapy (p = 0.04) in LGA patients and incomplete cytoreduction (p = 0.0003) and preoperative chemotherapy (p = 0.0064) in HGA patients. After complete cytoreduction, median survival was worse for patients with positive nodes than for those with negative nodes in LGA (85 months vs not reached [82 % alive at 90 months]; p = 0.002) and HGA (30 vs 153 months; p < 0.0001). CONCLUSIONS: Positive nodes are associated with decreased survival not only for HGA patients but also for LGA patients even after complete cytoreduction. Nodal status further stratifies histologic grade as a prognostic indicator of survival. Patients with node-negative HGA primary lesions who receive a complete cytoreduction may experience survival comparable with that for LGA patients. More... »

PAGES

1274-1279

Identifiers

URI

http://scigraph.springernature.com/pub.10.1245/s10434-014-4147-y

DOI

http://dx.doi.org/10.1245/s10434-014-4147-y

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1000934407

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/25319583


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Appendiceal Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chemotherapy, Cancer, Regional Perfusion", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Combined Modality Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cytoreduction Surgical Procedures", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Follow-Up Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hyperthermia, Induced", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Morbidity", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Staging", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Peritoneal Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prognosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Rate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Young Adult", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Wake Forest Baptist Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412860.9", 
          "name": [
            "Section of Surgical Oncology, Department of General Surgery, Wake Forest Baptist Health, Winston-Salem, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Votanopoulos", 
        "givenName": "Konstantinos I.", 
        "id": "sg:person.01155643513.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01155643513.53"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Wake Forest Baptist Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412860.9", 
          "name": [
            "Department of Biostatistical Sciences, Wake Forest Baptist Health, Winston-Salem, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Russell", 
        "givenName": "Greg", 
        "id": "sg:person.010655424252.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010655424252.42"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Wake Forest Baptist Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412860.9", 
          "name": [
            "Section of Surgical Oncology, Department of General Surgery, Wake Forest Baptist Health, Winston-Salem, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Randle", 
        "givenName": "Reese W.", 
        "id": "sg:person.0645016266.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0645016266.53"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Wake Forest Baptist Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412860.9", 
          "name": [
            "Section of Surgical Oncology, Department of General Surgery, Wake Forest Baptist Health, Winston-Salem, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shen", 
        "givenName": "Perry", 
        "id": "sg:person.01261074562.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01261074562.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Wake Forest Baptist Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412860.9", 
          "name": [
            "Section of Surgical Oncology, Department of General Surgery, Wake Forest Baptist Health, Winston-Salem, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Stewart", 
        "givenName": "John H.", 
        "id": "sg:person.01313762200.61", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01313762200.61"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Wake Forest Baptist Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412860.9", 
          "name": [
            "Section of Surgical Oncology, Department of General Surgery, Wake Forest Baptist Health, Winston-Salem, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Levine", 
        "givenName": "Edward A.", 
        "id": "sg:person.01362075400.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01362075400.37"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1245/s10434-007-9691-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005728651", 
          "https://doi.org/10.1245/s10434-007-9691-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1245/s10434-011-1840-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007049092", 
          "https://doi.org/10.1245/s10434-011-1840-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejso.2010.01.006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014202998"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.sla.0000133083.54934.ae", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024049438"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.sla.0000133083.54934.ae", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024049438"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.sla.0000133083.54934.ae", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024049438"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.sla.0000133183.15705.71", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035785933"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.sla.0000133183.15705.71", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035785933"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10434-006-9708-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035920713", 
          "https://doi.org/10.1007/s10434-006-9708-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10434-006-9708-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035920713", 
          "https://doi.org/10.1007/s10434-006-9708-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1245/s10434-011-1903-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037577562", 
          "https://doi.org/10.1245/s10434-011-1903-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdr279", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041946081"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/jso.21679", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043833239"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/jso.21679", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043833239"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jamcollsurg.2013.12.013", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044116652"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.pas.0000202039.74837.7d", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047139904"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.pas.0000202039.74837.7d", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047139904"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jamcollsurg.2006.12.048", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052968670"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2011.39.7166", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053361244"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2015-04", 
    "datePublishedReg": "2015-04-01", 
    "description": "BACKGROUND: Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) used to treat peritoneal surface disease (PSD) from appendiceal cancer have shown variability in survival outcomes. The primary goal of this study was to determine predictors of surgical morbidity and overall survival. The secondary goal was to describe the impact of nodal status on survival after CRS/HIPEC for PSD from low-grade appendiceal (LGA) and high-grade appendiceal (HGA) primary lesions.\nMETHODS: A retrospective analysis of 1,069 procedures from a prospective database was performed. Patient characteristics, tumor grade, nodal status, performance status, resection status, morbidity, mortality, and survival were reviewed.\nRESULTS: The study identified 481 CRS/HIPEC procedures: 317 (77.3 %) for LGA and 93 (22.7 %) for HGA lesions. The median follow-up period was 44.4 months, and the 30-day major morbidity and mortality rates were respectively 27.8 and 2.7 %. Major morbidity was jointly predicted by incomplete cytoreduction (p = 0.0037), involved nodes (p < 0.0001), and comorbidities (p = 0.003). Multivariate negative predictors of survival included positive nodal status (p = 0.003), incomplete cytoreduction (p < 0.0001), and preoperative chemotherapy (p = 0.04) in LGA patients and incomplete cytoreduction (p = 0.0003) and preoperative chemotherapy (p = 0.0064) in HGA patients. After complete cytoreduction, median survival was worse for patients with positive nodes than for those with negative nodes in LGA (85 months vs not reached [82 % alive at 90 months]; p = 0.002) and HGA (30 vs 153 months; p < 0.0001).\nCONCLUSIONS: Positive nodes are associated with decreased survival not only for HGA patients but also for LGA patients even after complete cytoreduction. Nodal status further stratifies histologic grade as a prognostic indicator of survival. Patients with node-negative HGA primary lesions who receive a complete cytoreduction may experience survival comparable with that for LGA patients.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1245/s10434-014-4147-y", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2438796", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1105545", 
        "issn": [
          "1068-9265", 
          "1534-4681"
        ], 
        "name": "Annals of Surgical Oncology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "22"
      }
    ], 
    "name": "Peritoneal Surface Disease (PSD) from Appendiceal Cancer Treated with Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Overview of 481 Cases", 
    "pagination": "1274-1279", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "0473cefde97b028706410aa80b0d7137aa856176654c79c3abbccb0a0406254f"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "25319583"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "9420840"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1245/s10434-014-4147-y"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1000934407"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1245/s10434-014-4147-y", 
      "https://app.dimensions.ai/details/publication/pub.1000934407"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T01:04", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8697_00000498.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1245/s10434-014-4147-y"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1245/s10434-014-4147-y'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1245/s10434-014-4147-y'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1245/s10434-014-4147-y'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1245/s10434-014-4147-y'


 

This table displays all metadata directly associated to this object as RDF triples.

238 TRIPLES      21 PREDICATES      64 URIs      43 LITERALS      31 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1245/s10434-014-4147-y schema:about N1699bf00faed4cfd85e06253b635b268
2 N18c5f564470a4e80a735b70ed2e52758
3 N3089b119c6b7404aa0bc94aa2df93bed
4 N37752098c86340f8a3b3e2275cb5624b
5 N3ab439336a43408fa822c2fcff3c2ce4
6 N3c7a1fb876a948b69cd64bcfc48554ac
7 N3ef40bd60ccc4ff785545ed53c3fe2be
8 N4efd00766c154e2db4d9a857813f1da2
9 N4f0d3484cfe14dc5b551cfe57864b61c
10 N5819fbfe43b4440d94a7dae546bce696
11 N76aa93a96a2a4eac8c4a0b21694c008e
12 N8597f00a5bef4351a3f2c940e618509e
13 N98caeecafdc34204bc697b9dd5e0e3b7
14 N9d49c46fc9854cbfa6c7f2431f808421
15 Na2e572aae16044709aa556df0f09a2b2
16 Na870f2ee9e594ebb96be9b09f37ca41a
17 Na8db1004046445c49b59653d359769a2
18 Nab30446ca800466991bdb74ece8d477d
19 Nd7137bafbea942a2ac828c5f997f9136
20 Ndbc9b84ccc8f4087a16b29fc6ff3e6d4
21 Nf85f247676de48a38a79c9438f5b6cdc
22 Nff61aed62db848fb9347efc04f6e1e22
23 anzsrc-for:11
24 anzsrc-for:1112
25 schema:author Ndde0d6ac60124cfb950749285cea0d08
26 schema:citation sg:pub.10.1007/s10434-006-9708-2
27 sg:pub.10.1245/s10434-007-9691-2
28 sg:pub.10.1245/s10434-011-1840-y
29 sg:pub.10.1245/s10434-011-1903-0
30 https://doi.org/10.1002/jso.21679
31 https://doi.org/10.1016/j.ejso.2010.01.006
32 https://doi.org/10.1016/j.jamcollsurg.2006.12.048
33 https://doi.org/10.1016/j.jamcollsurg.2013.12.013
34 https://doi.org/10.1093/annonc/mdr279
35 https://doi.org/10.1097/01.pas.0000202039.74837.7d
36 https://doi.org/10.1097/01.sla.0000133083.54934.ae
37 https://doi.org/10.1097/01.sla.0000133183.15705.71
38 https://doi.org/10.1200/jco.2011.39.7166
39 schema:datePublished 2015-04
40 schema:datePublishedReg 2015-04-01
41 schema:description BACKGROUND: Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) used to treat peritoneal surface disease (PSD) from appendiceal cancer have shown variability in survival outcomes. The primary goal of this study was to determine predictors of surgical morbidity and overall survival. The secondary goal was to describe the impact of nodal status on survival after CRS/HIPEC for PSD from low-grade appendiceal (LGA) and high-grade appendiceal (HGA) primary lesions. METHODS: A retrospective analysis of 1,069 procedures from a prospective database was performed. Patient characteristics, tumor grade, nodal status, performance status, resection status, morbidity, mortality, and survival were reviewed. RESULTS: The study identified 481 CRS/HIPEC procedures: 317 (77.3 %) for LGA and 93 (22.7 %) for HGA lesions. The median follow-up period was 44.4 months, and the 30-day major morbidity and mortality rates were respectively 27.8 and 2.7 %. Major morbidity was jointly predicted by incomplete cytoreduction (p = 0.0037), involved nodes (p < 0.0001), and comorbidities (p = 0.003). Multivariate negative predictors of survival included positive nodal status (p = 0.003), incomplete cytoreduction (p < 0.0001), and preoperative chemotherapy (p = 0.04) in LGA patients and incomplete cytoreduction (p = 0.0003) and preoperative chemotherapy (p = 0.0064) in HGA patients. After complete cytoreduction, median survival was worse for patients with positive nodes than for those with negative nodes in LGA (85 months vs not reached [82 % alive at 90 months]; p = 0.002) and HGA (30 vs 153 months; p < 0.0001). CONCLUSIONS: Positive nodes are associated with decreased survival not only for HGA patients but also for LGA patients even after complete cytoreduction. Nodal status further stratifies histologic grade as a prognostic indicator of survival. Patients with node-negative HGA primary lesions who receive a complete cytoreduction may experience survival comparable with that for LGA patients.
42 schema:genre research_article
43 schema:inLanguage en
44 schema:isAccessibleForFree true
45 schema:isPartOf N0cd8417e52234fcfb3cb7726b2a85b6b
46 N32dc25d6123f4e188de2f31edf2b56d1
47 sg:journal.1105545
48 schema:name Peritoneal Surface Disease (PSD) from Appendiceal Cancer Treated with Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Overview of 481 Cases
49 schema:pagination 1274-1279
50 schema:productId N3aec87a95a9a47d980e56b79e160af88
51 N9426303fa01e4c0b88e38b03964db045
52 Na3fdedddbfd8401b9b3f713ee203c4b2
53 Nf50624ddd45a4ce2a1bcd40ab2dcf364
54 Nfe1d0ac9303e49e7bdecee0d21a39ab8
55 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000934407
56 https://doi.org/10.1245/s10434-014-4147-y
57 schema:sdDatePublished 2019-04-11T01:04
58 schema:sdLicense https://scigraph.springernature.com/explorer/license/
59 schema:sdPublisher Nd58799b887254337b8cdb5541a141ee4
60 schema:url http://link.springer.com/10.1245/s10434-014-4147-y
61 sgo:license sg:explorer/license/
62 sgo:sdDataset articles
63 rdf:type schema:ScholarlyArticle
64 N0cd8417e52234fcfb3cb7726b2a85b6b schema:issueNumber 4
65 rdf:type schema:PublicationIssue
66 N15ba0b58db9e43dfbf33a2ccb09331a7 rdf:first sg:person.01313762200.61
67 rdf:rest N4a1f5b22c25a46fe9c56d0a588acdf27
68 N1635d856e41a4cd48e1cd4f0f7734573 rdf:first sg:person.010655424252.42
69 rdf:rest N9fda02235e8046d9b35b2beb60613cb8
70 N1699bf00faed4cfd85e06253b635b268 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
71 schema:name Retrospective Studies
72 rdf:type schema:DefinedTerm
73 N18c5f564470a4e80a735b70ed2e52758 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
74 schema:name Adult
75 rdf:type schema:DefinedTerm
76 N3089b119c6b7404aa0bc94aa2df93bed schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
77 schema:name Survival Rate
78 rdf:type schema:DefinedTerm
79 N32dc25d6123f4e188de2f31edf2b56d1 schema:volumeNumber 22
80 rdf:type schema:PublicationVolume
81 N37752098c86340f8a3b3e2275cb5624b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
82 schema:name Prospective Studies
83 rdf:type schema:DefinedTerm
84 N3ab439336a43408fa822c2fcff3c2ce4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
85 schema:name Neoplasm Staging
86 rdf:type schema:DefinedTerm
87 N3aec87a95a9a47d980e56b79e160af88 schema:name pubmed_id
88 schema:value 25319583
89 rdf:type schema:PropertyValue
90 N3c7a1fb876a948b69cd64bcfc48554ac schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
91 schema:name Male
92 rdf:type schema:DefinedTerm
93 N3ef40bd60ccc4ff785545ed53c3fe2be schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
94 schema:name Aged
95 rdf:type schema:DefinedTerm
96 N4a1f5b22c25a46fe9c56d0a588acdf27 rdf:first sg:person.01362075400.37
97 rdf:rest rdf:nil
98 N4efd00766c154e2db4d9a857813f1da2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Prognosis
100 rdf:type schema:DefinedTerm
101 N4f0d3484cfe14dc5b551cfe57864b61c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Aged, 80 and over
103 rdf:type schema:DefinedTerm
104 N5819fbfe43b4440d94a7dae546bce696 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Follow-Up Studies
106 rdf:type schema:DefinedTerm
107 N76aa93a96a2a4eac8c4a0b21694c008e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Cytoreduction Surgical Procedures
109 rdf:type schema:DefinedTerm
110 N8597f00a5bef4351a3f2c940e618509e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Combined Modality Therapy
112 rdf:type schema:DefinedTerm
113 N9426303fa01e4c0b88e38b03964db045 schema:name dimensions_id
114 schema:value pub.1000934407
115 rdf:type schema:PropertyValue
116 N98caeecafdc34204bc697b9dd5e0e3b7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Peritoneal Neoplasms
118 rdf:type schema:DefinedTerm
119 N9d49c46fc9854cbfa6c7f2431f808421 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Young Adult
121 rdf:type schema:DefinedTerm
122 N9fda02235e8046d9b35b2beb60613cb8 rdf:first sg:person.0645016266.53
123 rdf:rest Nd117c48de0f94828b3a318b03601c71e
124 Na2e572aae16044709aa556df0f09a2b2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Chemotherapy, Cancer, Regional Perfusion
126 rdf:type schema:DefinedTerm
127 Na3fdedddbfd8401b9b3f713ee203c4b2 schema:name readcube_id
128 schema:value 0473cefde97b028706410aa80b0d7137aa856176654c79c3abbccb0a0406254f
129 rdf:type schema:PropertyValue
130 Na870f2ee9e594ebb96be9b09f37ca41a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Morbidity
132 rdf:type schema:DefinedTerm
133 Na8db1004046445c49b59653d359769a2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Humans
135 rdf:type schema:DefinedTerm
136 Nab30446ca800466991bdb74ece8d477d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Female
138 rdf:type schema:DefinedTerm
139 Nd117c48de0f94828b3a318b03601c71e rdf:first sg:person.01261074562.24
140 rdf:rest N15ba0b58db9e43dfbf33a2ccb09331a7
141 Nd58799b887254337b8cdb5541a141ee4 schema:name Springer Nature - SN SciGraph project
142 rdf:type schema:Organization
143 Nd7137bafbea942a2ac828c5f997f9136 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Appendiceal Neoplasms
145 rdf:type schema:DefinedTerm
146 Ndbc9b84ccc8f4087a16b29fc6ff3e6d4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Antineoplastic Combined Chemotherapy Protocols
148 rdf:type schema:DefinedTerm
149 Ndde0d6ac60124cfb950749285cea0d08 rdf:first sg:person.01155643513.53
150 rdf:rest N1635d856e41a4cd48e1cd4f0f7734573
151 Nf50624ddd45a4ce2a1bcd40ab2dcf364 schema:name nlm_unique_id
152 schema:value 9420840
153 rdf:type schema:PropertyValue
154 Nf85f247676de48a38a79c9438f5b6cdc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Middle Aged
156 rdf:type schema:DefinedTerm
157 Nfe1d0ac9303e49e7bdecee0d21a39ab8 schema:name doi
158 schema:value 10.1245/s10434-014-4147-y
159 rdf:type schema:PropertyValue
160 Nff61aed62db848fb9347efc04f6e1e22 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Hyperthermia, Induced
162 rdf:type schema:DefinedTerm
163 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
164 schema:name Medical and Health Sciences
165 rdf:type schema:DefinedTerm
166 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
167 schema:name Oncology and Carcinogenesis
168 rdf:type schema:DefinedTerm
169 sg:grant.2438796 http://pending.schema.org/fundedItem sg:pub.10.1245/s10434-014-4147-y
170 rdf:type schema:MonetaryGrant
171 sg:journal.1105545 schema:issn 1068-9265
172 1534-4681
173 schema:name Annals of Surgical Oncology
174 rdf:type schema:Periodical
175 sg:person.010655424252.42 schema:affiliation https://www.grid.ac/institutes/grid.412860.9
176 schema:familyName Russell
177 schema:givenName Greg
178 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010655424252.42
179 rdf:type schema:Person
180 sg:person.01155643513.53 schema:affiliation https://www.grid.ac/institutes/grid.412860.9
181 schema:familyName Votanopoulos
182 schema:givenName Konstantinos I.
183 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01155643513.53
184 rdf:type schema:Person
185 sg:person.01261074562.24 schema:affiliation https://www.grid.ac/institutes/grid.412860.9
186 schema:familyName Shen
187 schema:givenName Perry
188 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01261074562.24
189 rdf:type schema:Person
190 sg:person.01313762200.61 schema:affiliation https://www.grid.ac/institutes/grid.412860.9
191 schema:familyName Stewart
192 schema:givenName John H.
193 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01313762200.61
194 rdf:type schema:Person
195 sg:person.01362075400.37 schema:affiliation https://www.grid.ac/institutes/grid.412860.9
196 schema:familyName Levine
197 schema:givenName Edward A.
198 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01362075400.37
199 rdf:type schema:Person
200 sg:person.0645016266.53 schema:affiliation https://www.grid.ac/institutes/grid.412860.9
201 schema:familyName Randle
202 schema:givenName Reese W.
203 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0645016266.53
204 rdf:type schema:Person
205 sg:pub.10.1007/s10434-006-9708-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035920713
206 https://doi.org/10.1007/s10434-006-9708-2
207 rdf:type schema:CreativeWork
208 sg:pub.10.1245/s10434-007-9691-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005728651
209 https://doi.org/10.1245/s10434-007-9691-2
210 rdf:type schema:CreativeWork
211 sg:pub.10.1245/s10434-011-1840-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1007049092
212 https://doi.org/10.1245/s10434-011-1840-y
213 rdf:type schema:CreativeWork
214 sg:pub.10.1245/s10434-011-1903-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037577562
215 https://doi.org/10.1245/s10434-011-1903-0
216 rdf:type schema:CreativeWork
217 https://doi.org/10.1002/jso.21679 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043833239
218 rdf:type schema:CreativeWork
219 https://doi.org/10.1016/j.ejso.2010.01.006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014202998
220 rdf:type schema:CreativeWork
221 https://doi.org/10.1016/j.jamcollsurg.2006.12.048 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052968670
222 rdf:type schema:CreativeWork
223 https://doi.org/10.1016/j.jamcollsurg.2013.12.013 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044116652
224 rdf:type schema:CreativeWork
225 https://doi.org/10.1093/annonc/mdr279 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041946081
226 rdf:type schema:CreativeWork
227 https://doi.org/10.1097/01.pas.0000202039.74837.7d schema:sameAs https://app.dimensions.ai/details/publication/pub.1047139904
228 rdf:type schema:CreativeWork
229 https://doi.org/10.1097/01.sla.0000133083.54934.ae schema:sameAs https://app.dimensions.ai/details/publication/pub.1024049438
230 rdf:type schema:CreativeWork
231 https://doi.org/10.1097/01.sla.0000133183.15705.71 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035785933
232 rdf:type schema:CreativeWork
233 https://doi.org/10.1200/jco.2011.39.7166 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053361244
234 rdf:type schema:CreativeWork
235 https://www.grid.ac/institutes/grid.412860.9 schema:alternateName Wake Forest Baptist Medical Center
236 schema:name Department of Biostatistical Sciences, Wake Forest Baptist Health, Winston-Salem, NC, USA
237 Section of Surgical Oncology, Department of General Surgery, Wake Forest Baptist Health, Winston-Salem, NC, USA
238 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...